IPI vs MATV
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
IPI exhibits strong deterministic health with a Piotroski F-Score of 7/9 and a nearly debt-free balance sheet (Debt/Equity 0.01). However, the stock is significantly overvalued relative to its Graham Number ($26.75) and Intrinsic Value ($5.95), trading at a steep premium. While explosive YoY EPS growth (+545.5%) and a PEG ratio of 0.96 provide a growth-based justification, the bearish technical trend and a lone analyst target of $25.00 suggest a high risk of price correction.
MATV exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. While the stock has seen a strong 1-year price recovery, this is not supported by operational growth, as revenue growth is stagnant at 1%. The company is burdened by high leverage (Debt/Equity of 2.17) and an unsustainable dividend payout ratio of 120.28%. Despite a low Price/Sales ratio, the negative profit margins and poor ROE suggest a value trap rather than a value opportunity.
Compare Another Pair
Related Comparisons
IPI vs MATV: Head-to-Head Comparison
This page compares Intrepid Potash, Inc. (IPI) and Mativ Holdings, Inc. (MATV) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.